Member Exclusive

Nanotechnology utilized to deliver targeted treatments for lung infection

Researchers from Massachusetts Institute of Technology (Cambridge, MA, USA) have developed a targeted antimicrobial treatment, that dramatically reduces the number of bacteria in the lungs of mice infected with Pseudomonas aeruginosa.

Go to the profile of Rachel Coleby
Jul 20, 2017
0
0

Please sign in or register for FREE

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.